Legal & General Group PLC Aurinia Pharmaceuticals Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 136,224 shares of AUPH stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,224
Previous 136,224 -0.0%
Holding current value
$1.3 Million
Previous $998,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.32 - $7.33 $5,878 - $8,099
-1,105 Reduced 0.8%
136,224 $998,000
Q2 2024

Aug 14, 2024
BUY
$4.81 - $5.78 $26,791 - $32,194
5,570 Added 4.23%
137,329 $784,000
Q1 2024

May 14, 2024
SELL
$4.93 - $9.31 $4,121 - $7,783
-836 Reduced 0.63%
131,759 $660,000
Q4 2023

Feb 15, 2024
BUY
$7.13 - $9.49 $11,108 - $14,785
1,558 Added 1.19%
132,595 $1.19 Million
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $57,583 - $90,932
7,411 Added 5.99%
131,037 $1.02 Million
Q2 2023

Aug 14, 2023
BUY
$8.96 - $11.69 $2,965 - $3,869
331 Added 0.27%
123,626 $1.2 Million
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $27,549 - $52,270
4,638 Added 3.91%
123,295 $1.35 Million
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $7,714 - $15,278
1,877 Added 1.61%
118,657 $512,000
Q3 2022

Nov 14, 2022
SELL
$6.66 - $12.39 $66,147 - $123,057
-9,932 Reduced 7.84%
116,780 $878,000
Q2 2022

Aug 22, 2022
BUY
$8.95 - $12.8 $325,627 - $465,702
36,383 Added 40.28%
126,712 $1.27 Million
Q1 2022

May 16, 2022
BUY
$10.05 - $22.48 $547,875 - $1.23 Million
54,515 Added 152.22%
90,329 $1.12 Million
Q4 2021

Feb 14, 2022
SELL
$17.78 - $33.08 $76,418 - $142,177
-4,298 Reduced 10.71%
35,814 $819,000
Q3 2021

Nov 15, 2021
BUY
$10.93 - $23.55 $381,249 - $821,447
34,881 Added 666.81%
40,112 $841,000
Q3 2020

Nov 13, 2020
BUY
$13.19 - $16.66 $18,848 - $23,807
1,429 Added 37.59%
5,231 $77,000
Q4 2019

Feb 13, 2020
BUY
$3.88 - $21.42 $5,754 - $31,765
1,483 Added 63.95%
3,802 $77,000
Q1 2019

May 15, 2019
BUY
$6.06 - $7.64 $14,053 - $17,717
2,319 New
2,319 $15,000
Q3 2018

Nov 20, 2018
SELL
$5.27 - $6.64 $12,273 - $15,464
-2,329 Closed
0 $0
Q1 2018

May 17, 2018
BUY
$4.85 - $5.99 $11,295 - $13,950
2,329 New
2,329 $12,000

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.36B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email